๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adherence in liver transplant recipients

โœ Scribed by Patrizia Burra; Giacomo Germani; Francesca Gnoato; Silvia Lazzaro; Francesco Paolo Russo; Umberto Cillo; Marco Senzolo


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
135 KB
Volume
17
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

โœฆ Synopsis


Adherence to a medical regimen has been defined as the extent to which a patient's behavior coincides with clinical prescriptions. In liver transplant patients, adherence to immunosuppressive therapy and to medical indications in general is crucial for short-and long-term outcomes. Nonadherence to immunosuppression carries a risk of graft rejection and potential graft loss, whereas nonadherence to general medical indications (eg, avoiding alcohol intake and smoking after transplantation) may be associated with other complications such as de novo tumors and increasing health care costs. Among adult liver transplant patients, the rate of nonadherence to immunosuppressive drugs ranges from 15% to 40%, whereas the rate of nonadherence to clinical appointments ranges from 3% to 47%. The wide range of reported rates is due to different definitions of the term nonadherence and the variety of methods used to measure adherence in the medical literature. Nonadherence seems to be nearly 4 times higher in pediatric and adolescent patients versus adult transplant recipients. Several nonadherence risk factors, such as high medication costs, psychiatric disorders, the conviction that the medication is harmful, and side effects of immunosuppressive therapy, have been described among adult liver transplant patients. The risk factors for nonadherence in pediatric and adolescent liver transplant patients are psychological distress, the functional status of their families, and the impact of immunosuppressive side effects on their physical appearance. A single approach to promoting adherence to general medical prescriptions has been proved to be ineffectual, so a multidisciplinary strategy should be adopted to achieve significant improvements in this field. The aim of this review is to analyze the published literature on adherence in liver transplant patients with a particular focus on the reported prevalence and the identified risk factors. Patients have been split into 2 age groups (adults and children/adolescents) because the scale of the problem and the potential risk factors differ in the 2 groups.


๐Ÿ“œ SIMILAR VOLUMES


Antifungal prophylaxis in liver transpla
โœ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse

Hepatitis B in liver transplant recipien
โœ Robert G. Gish; Timothy McCashland ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB ๐Ÿ‘ 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire

Smoking behavior in liver transplant rec
โœ Frans van der Heide; Gerard Dijkstra; Robert J. Porte; Jan H. Kleibeuker; Elizab ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB

Long-term morbidity and survival after orthotopic liver transplantation (OLT) are to a large degree determined by cardiovascular disease and cancer. Tobacco use is a well-known risk factor for both. The aim of this study was to examine smoking behavior before and after OLT and to define groups at ri

Appendicitis among liver transplant reci
โœ Peter L. Abt; Ibrahim Abdullah; Kathleen Korenda; Adam Frank; Heather Peterman; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB

Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majo

Epileptiform electroencephalographic abn
โœ Z. K. Wszolek; Dr. A. J. Aksamit; R. J. Ellingson; F. W. Sharbrough; B. F. Westm ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 472 KB ๐Ÿ‘ 2 views

## Abstract We retrospectively studied patients who had undergone orthotopic liver transplantation and who also had electroencephalography to determine whether epileptiform changes were associated with a poor neurological outcome. Study groups were 36 patients who died after transplantation (141 el

Mini-microabscess syndrome in liver tran
โœ G A MacDonald; J K Greenson; E A DelBuono; W M Grady; R M Merion; T S Frank; M R ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 436 KB

retinitis, duodenal and/or colonic involvement, or dissemi-Cytomegalovirus (CMV) is a significant cause of morbidity nated disease. [2][3][4] CMV infection after OLT has been linked to in immunosuppressed patients. It is characterized in the liver decreased patient survival, particularly in studies